http://www.acc.org/Feed?clinicalTopicID=3c5813ed-5b04-49ba-9134-96a6d8bfc120 Clinical Topic Feed: Heart Failure and Cardiac Biomarkers en /Latest-in-Cardiology/Articles/2026/09/16/14/20/eagles-eye-view-16sep2026 In this week’s View, Dr. Eagle looks at a recent article on proposed changes to the current cardiovascular (CV) subspecialty training path. 1789568460000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/09/10/13/51/Look-AHEAD The inflammatory biomarker interleukin (IL)-6 identified residual inflammatory risk of incident heart failure (HF) in patients with type 2 diabetes (T2D) and overweight/obesity, particularly among those with no history of cardiovascular disease, according to results of a Look AHEAD ancillary study published Sept. 3 in JACC: Heart Failure. 1789072260000 Articles and Stories /Latest-in-Cardiology/Articles/2026/08/26/13/33/eagles-eye-view-26aug2026 In this week’s View, Dr. Eagle looks at the relationship between lower cardiorespiratory fitness (CRF) and higher coronary artery calcium scores (CAC) and later-life dementia. 1787751300000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/08/18/18/12/TARTAN-HF A heart failure (HF) screening strategy focused on NT-proBNP identified a large proportion of patients with diabetes who had previously unrecognized but symptomatic HF, according to research published Aug. 19 in JACC. 1787151000000 Articles and Stories /Latest-in-Cardiology/Articles/2026/07/01/12/47/eagles-eye-view-01jul2026 In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM). 1782910140000 Articles and Stories /Latest-in-Cardiology/Articles/2026/06/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1780315620000 Articles and Stories /Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026 In this week’s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment. 1779288780000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/Incorporating-CMR-and-NT-proBNP Results from a prospective study using data from the National Heart, Lung, and Blood Institute’s Hypertrophic Cardiomyopathy (HCM) Registry provide important evidence in support of incorporating cardiac magnetic resonance (CMR) imaging and NT-proBNP into the evaluation of risk in patients with HCM. 1778516640000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2026/03/19/17/12/Dobermann Two brief reports in JACC on the DOBERMANN-T and DOBERMANN-D trials found that among patients with acute myocardial infarction (AMI) at increased risk of cardiogenic shock (CS), early interleukin 6 (IL 6) receptor inhibition with tocilizumab safely reduced systemic inflammation but showed inconclusive effects on NT proBNP. In contrast, early dobutamine infusion did not lower NT proBNP levels but did reduce systolic blood pressure (SBP) without raising safety concerns. 1773942840000 Articles and Stories /Latest-in-Cardiology/Articles/2025/11/06/13/19/JACC-Journals-Publish-Latest-Science-From-aha-2025 AHA 2025 features key science simultaneously published across ACC's JACC Journals, including JACC, JACC: CardioOncology, JACC: Advances, JACC: Case Reports, JACC: Heart Failure and JACC: Cardiovascular Imaging. 1762527600000 Articles and Stories